Magdalena Czajka

Mrs. Magdalena Czajka

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Toxicology in Vitro
Verified
Journal Article
Closed access
MCMagdalena Czajka
Magdalena Czajka
KSKrzysztof Sawicki
Krzysztof Sawicki
KSKatarzyna Sikorska
Katarzyna Sikorska
SPSylwia Popek
Sylwia Popek
Marcin KruszewskiMarcin Kruszewski
Marcin Kruszewski
Lucyna Kapka-SkrzypczakLucyna Kapka-Skrzypczak
Lucyna Kapka-Skrzypczak

1 November 2019 in Environmental Research
Verified
Journal Article
Closed access
MCMagdalena Czajka
Magdalena Czajka
MMMagdalena Matysiak-Kucharek
Magdalena Matysiak-Kucharek
BJBarbara Jodłowska-Jędrych
Barbara Jodłowska-Jędrych
KSKrzysztof Sawicki
Krzysztof Sawicki
BFBerta Fal
Berta Fal
Lucyna Kapka-SkrzypczakLucyna Kapka-Skrzypczak
Lucyna Kapka-Skrzypczak

6 November 2019 in Nanotechnology Reviews
Verified
Journal Article
Open access
PDF file
KSKrzysztof Sawicki
Krzysztof Sawicki
MCMagdalena Czajka
Magdalena Czajka
MMMagdalena Matysiak-Kucharek
Magdalena Matysiak-Kucharek
BFBerta Fal
Berta Fal
BDBartlomiej Drop
Bartlomiej Drop
Lucyna Kapka-SkrzypczakLucyna Kapka-Skrzypczak
Lucyna Kapka-Skrzypczak
Metallic nanoparticles due to their small size and unique physico-chemical characteristics have found excellent applications in various branches of industry and medicine. Therefore, for many years a growing interest has been observed among the scientific community in the improvement of our understanding of the impact of nanoparticles on the living organisms, especially on humans. Considering the delicate structure of the central nervous systemit is one of the organs most vulnerable to the adverse effects of metallic nanoparticles. For that reason, it is important to identify the modes of exposure and understand the mechanisms of the effect of nanoparticles on neuronal tissue. In this review, an attempt is undertaken to present current knowledge about metallic nanoparticles neurotoxicity based on the selected scientific publications. The route of entry of nanoparticles is described, as well as their distribution, penetration through the cell membrane and the blood-brain barrier. In addition, a study on the neurotoxicityin vitroandin vivois presented, as well as some of the mechanisms that may be responsible for the negative effects of metallic nanoparticles on the central nervous system. Graphical abstract:This review summarizes the current knowledge on the toxicity of metallic NPs in the brain and central nervous system of the higher vertebrates.

12 May 2020 in Materials
Verified
Journal Article
Open access
PDF file
SMSylwia Męczyńska-Wielgosz
Sylwia Męczyńska-Wielgosz
MWMaria Wojewódzka
Maria Wojewódzka
MMMagdalena Matysiak-Kucharek
Magdalena Matysiak-Kucharek
MCMagdalena Czajka
Magdalena Czajka
BJBarbara Jodłowska-Jędrych
Barbara Jodłowska-Jędrych
Lucyna Kapka-SkrzypczakLucyna Kapka-Skrzypczak
Lucyna Kapka-Skrzypczak
The fast-growing use of nanomaterials in everyday life raises the question about the safety of their use. Unfortunately, the risks associated with the use of nanoparticles (NPs) have not yet been fully assessed. The majority of studies conducted so far at the molecular and cellular level have focused on a single-type exposure, assuming that NPs act as the only factor. In the natural environment, however, we are likely exposed to a mixture of nanoparticles, whose interactions may modulate their impact on living organisms. This study aimed to evaluate the toxicological effects caused by in vitro exposure of HepG2 cells to AgNPs in combination with AuNPs, CdTe quantum dot (QD) NPs, TiO2NPs, or SiO2NPs. The results showed that the toxicity of nanoparticle binary mixtures depended on the type and ratio of NPs used. In general, the toxicity of binary mixtures of NPs was lower than the sum of toxicities of NPs alone (protective effect).

23 January 2019 in Molecular Medicine Reports
Verified
Journal Article
Closed access
PDF file
Lucyna Kapka-SkrzypczakLucyna Kapka-Skrzypczak
Lucyna Kapka-Skrzypczak
SPSylwia Popek-Marciniec
Sylwia Popek-Marciniec
KSKrzysztof Sawicki
Krzysztof Sawicki
BDBartlomiej Drop
Bartlomiej Drop
MCMagdalena Czajka
Magdalena Czajka
MKMarcin Kruszewski
Marcin Kruszewski
Epithelial cell adhesion molecule (EpCAM), which is expressed in the majority of epithelial tissues, exhibits tumor growth promoting abilities and is overexpressed in human epithelial ovarian cancer. Therefore, EpCAM is considered to be a promising target for specific immune‑based therapies. The present study evaluated the role of IL‑6 and IL‑8 in the expression of EpCAM in the A2780 human ovarian cancer cell line. Furthermore, the cellular localization of the EpCAM protein in A2780 cells was determined and the effect of EpCAM inhibition on the proliferation of the A2780 cells was investigated. An MTT assay demonstrated that blocking EpCAM with anti‑EPCAM antibodies had no effect on cellular metabolic activity (proliferation). Gene expression analysis revealed that IL‑8 increased EpCAM expression, whereas IL‑6 and the combination of IL‑6/IL‑8 had no effect on EpCAM expression. Immunofluorescence analysis confirmed that EpCAM is expressed on A2780 cell membranes. The present results demonstrated that IL‑8 increased EpCAM expression at the mRNA level in ovarian cancer cells and suggested a potential role of IL‑6 as an inhibitor of IL‑8‑stimulated EpCAM expression.

1 October 2015 in Immunology Letters
Verified
Journal Article
Closed access
Lucyna Kapka-SkrzypczakLucyna Kapka-Skrzypczak
Lucyna Kapka-Skrzypczak
EWE. Wolinska
E. Wolinska
GSG. Szparecki
G. Szparecki
GWGrzegorz Wilczynski
Grzegorz Wilczynski
MCMagdalena Czajka
Magdalena Czajka
MSMaciej Skrzypczak
Maciej Skrzypczak